Assessing combined effects of risk analysis index-revised (RAI-rev), malnutrition, and anemia on morbidity and mortality after spine surgery for metastatic spinal tumors
This study evaluates the combined effects of frailty, anemia, and malnutrition on outcomes in spinal metastases patients.
We conducted a retrospective cohort study using the 2011-2022 NSQIP database. Adult patients undergoing spinal surgery for spinal metastases were identified using CPT and ICD codes and stratified based on Risk Analysis Index-revised (RAI-rev) frailty status; frail patients were subdivided based on anemia and malnutrition status. Our primary outcomes were extended hospital length of stay (LOS), 30-day adverse events (AEs), non-routine discharge (NRD), and 30-day mortality. For each outcome, we fitted four nested multivariable logistic regression models (RAI-rev + anemia + malnutrition, RAI-rev + anemia, RAI-rev + malnutrition, and RAI-rev alone) and compared the incremental discrimination of each model using receiver operating characteristic (ROC) analysis.
1530 patients were stratified accordingly: 355 Frail Alone, 540 Frail + Anemic, 85 Frail + Malnourished, 407 Frail + Anemic + Malnourished, and 143 Not Frail. RAI-rev and malnourishment were risk factors for extended LOS ((RAI-rev: aOR 1.04, 95% CI 1.01-1.08; malnourishment: aOR 1.98, 95% CI 1.44-2.73)) and mortality (RAI-rev: aOR: 1.07, 95% CI 1.03-1.11; malnourishment: aOR: 2.37, 95% CI 1.50-3.75). RAI-rev (aOR 1.02, 95% CI 1.00-1.03) and anemia (aOR 2.06, 95% CI 1.50-2.84) independently predicted AEs and malnourishment predicted NRD (aOR 1.56, 95% CI 1.15-2.13). On ROC analysis, RAI-rev + anemic + malnourished superiorly predicted extended LOS (p = 0.021), AEs (p = 0.035), and mortality (p = 0.023) compared to RAI-rev. RAI-rev + malnourished outperformed RAI-rev in predicting extended LOS (p = 0.035) and mortality (p = 0.020). RAI-rev + anemic outperformed RAI-rev in predicting AEs (p = 0.032).
Our study suggests that RAI-rev-defined frailty combined with anemia and malnutrition is a superior predictor of outcomes in spinal metastases patients.
Anemia; Frailty; Malnutrition; Metastatic spinal tumors; Morbidity; RAI.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: Ethics committee approval was waived for the collection, analysis and publication of the retrospectively obtained and anonymized data for this non-interventional study. Consent to participant: NSQIP is a national database with de-identified information and therefore consent is waived. Consent for publication: Informed consent for information published in this article was not obtained because all information was de-identified.
- Steinberger JM, Yuk F, Doshi AH, Green S, Germano IM (2020) Multidisciplinary management of metastatic spine disease: initial symptom-directed management. Neuro-Oncology Practice 7:i33–i44. https://doi.org/10.1093/nop/npaa048 - DOI - PubMed - PMC